Abstract:A variety of factors, whether extracellular (mutagens/carcinogens and viruses in the environment, chronic inflammation and radiation associated with the environment and/or electronic devices/machines) and/or intracellular (oxidative metabolites of food, oxidative stress due to inflammation, acid production, replication stress, DNA replication/repair errors, and certain hormones, cytokines, growth factors), pose a constant threat to the genomic integrity of a living cell. However, in the normal cellular environment multiple biological pathways including DNA repair, cell cycle, apoptosis and the immune system work in a precise, regulated (tightly controlled), timely and concerted manner to ensure genomic integrity, stability and proper functioning of a cell. If damage to DNA takes place, it is efficiently and accurately repaired by the DNA repair systems. Homologous recombination (HR) which utilizes either a homologous chromosome (in G1 phase) or a sister chromatid (in G2) as a template to repair the damage, is known to be the most precise repair system. HR in G2 which utilizes a sister chromatid as a template is also called an error free repair system. If DNA damage in a cell is so extensive that it overwhelms the repair system/s, the cell is eliminated by apoptosis. Thus, multiple pathways ensure that genome of a cell is intact and stable. However, constant exposure to DNA damage and/or dysregulation of DNA repair mechanism/s poses a risk of mutation and cancer. Oncogenesis, which seems to be a multistep process, is associated with acquisition of a number of genomic changes that enable a normal cell to progress from benign to malignant transformation. Transformed/cancer cells are recognized and killed by the immune system. However, the ongoing acquisition of new genomic changes enables cancer cells to survive/escape immune attack, evolve into a more aggressive phenotype, and eventually develop resistance to therapy. Although DNA repair (especially the HR) and the immune system play unique roles in preserving genomic integrity of a cell, they can also contribute to DNA damage, genomic instability and oncogenesis. The purpose of this article is to highlight the roles of DNA repair (especially HR) and the immune system in genomic evolution, with special focus on gastrointestinal cancer.

Role of Base Excision Repair in Innate Immune Cells and Its Relevance for Cancer Therapy

Targeting the DNA Repair Pathway for Breast Cancer Therapy: Beyond the Molecular Subtypes.

Significance of base excision repair to human health

Targeting DNA repair pathways: a novel approach to reduce cancer therapeutic resistance.

DNA damage repair and cancer immunotherapy

Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy

DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy

Dysregulation of base excision repair factors associated with low tumor immunogenicity in head and neck cancer: implication for immunotherapy

Base Excision Repair and Design of Small Molecule Inhibitors of Human DNA Polymerase Β

Targeting DNA Repair Pathways: Mechanisms and Potential Applications in Cancer Therapy

DNA Repair Pathways in Cancer Therapy and Resistance.

The roles of homologous recombination and the immune system in the genomic evolution of cancer

DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining Immunotherapy

Complex Interplay between DNA Damage and Autophagy in Disease and Therapy

DNA Damage and Its Role in Cancer Therapeutics

Targeting DNA damage response pathways in cancer

Comprehensive exploration on the role of base excision repair genes in modulating immune infiltration in low-grade glioma

When DNA damage responses meet tumor immunity: From mechanism to therapeutic opportunity

Role of Base Excision Repair Pathway in the Processing of Complex DNA Damage Generated by Oxidative Stress and Anticancer Drugs

DNA repair-dependent immunogenic liabilities in colorectal cancer: opportunities from errors

Molecular dynamics of DNA repair and carcinogen interaction: Implications for cancer initiation, progression, and therapeutic strategies